Direct interaction of Ras and the amino-terminal region of Raf-1 in vitro
- PMID: 8332195
- DOI: 10.1038/364352a0
Direct interaction of Ras and the amino-terminal region of Raf-1 in vitro
Abstract
The Ras proteins are key regulators of the growth of eukaryotic cells, but their direct target enzymes, or 'effectors', are unknown. The protein encoded by the c-raf-1 proto-oncogene is thought to function downstream of p21ras because disruption of Raf blocks signalling by Ras in a number of systems. Here we report that the amino-terminal cysteine-rich regulatory region of p74c-raf-1 expressed as a glutathione-S-transferase (GST) fusion protein binds directly to Ras with relatively high affinity (50 nM). The binding is strictly dependent on the Ras protein being in the active GTP-bound conformation rather than the inactive GDP-bound state. Raf-GST interacts with wild-type and oncogenic Ras (Val 12) but fails to interact with a biologically inert effector mutant of Ras (Ala 38) and a dominant negative mutant (Asn 17). A peptide based on the effector region of Ras inhibits the interaction. Raf-GST acts as a potent competitive inhibitor of the GTPase-activating proteins p120GAP and neurofibromin. In addition, Raf itself displays weak GTPase-stimulating activity towards Ras. It is therefore likely that Raf is a direct effector of Ras.
Similar articles
-
Normal and oncogenic p21ras proteins bind to the amino-terminal regulatory domain of c-Raf-1.Nature. 1993 Jul 22;364(6435):308-13. doi: 10.1038/364308a0. Nature. 1993. PMID: 8332187
-
Different structural requirements within the switch II region of the Ras protein for interactions with specific downstream targets.Oncogene. 1995 Aug 3;11(3):447-54. Oncogene. 1995. PMID: 7630628
-
Activated Ras displaces 14-3-3 protein from the amino terminus of c-Raf-1.Oncogene. 1996 Feb 1;12(3):609-19. Oncogene. 1996. PMID: 8637718
-
Interactions between Ras and Raf: key regulatory proteins in cellular transformation.Mol Reprod Dev. 1995 Dec;42(4):493-9. doi: 10.1002/mrd.1080420418. Mol Reprod Dev. 1995. PMID: 8607981 Review.
-
Ras regulatory interactions: novel targets for anti-cancer intervention?Bioessays. 1994 Mar;16(3):187-91. doi: 10.1002/bies.950160309. Bioessays. 1994. PMID: 8166672 Review.
Cited by
-
Direct small-molecule inhibitors of KRAS: from structural insights to mechanism-based design.Nat Rev Drug Discov. 2016 Nov;15(11):771-785. doi: 10.1038/nrd.2016.139. Epub 2016 Jul 29. Nat Rev Drug Discov. 2016. PMID: 27469033 Review.
-
A recombinant chimeric protein specifically induces mutant KRAS degradation and potently inhibits pancreatic tumor growth.Oncotarget. 2016 Jul 12;7(28):44299-44309. doi: 10.18632/oncotarget.9996. Oncotarget. 2016. PMID: 27322423 Free PMC article.
-
Regulation of voltage-dependent calcium channels in rat sensory neurones involves a Ras-mitogen-activated protein kinase pathway.J Physiol. 2000 Sep 15;527 Pt 3(Pt 3):433-44. doi: 10.1111/j.1469-7793.2000.00433.x. J Physiol. 2000. PMID: 10990531 Free PMC article.
-
Development of small-molecule therapeutics and strategies for targeting RAF kinase in BRAF-mutant colorectal cancer.Cancer Manag Res. 2018 Aug 1;10:2289-2301. doi: 10.2147/CMAR.S170105. eCollection 2018. Cancer Manag Res. 2018. PMID: 30122982 Free PMC article. Review.
-
Tyrosine kinase signalling in breast cancer: tyrosine kinase-mediated signal transduction in transgenic mouse models of human breast cancer.Breast Cancer Res. 2000;2(3):211-6. doi: 10.1186/bcr56. Epub 2000 Apr 12. Breast Cancer Res. 2000. PMID: 11250712 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous
